Trial Profile
A study to investigate the duration of maintained efficacy in patients with rheumatoid arthritis who had treated with MRA [tocilizumab]
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Chugai Pharmaceutical
- 01 Aug 2012 Actual end date (1 May 2010) added as reported by ClinicalTrials.gov.
- 01 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 13 May 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.